LivaNova PLC Files 8-K with Regulatory Updates
Ticker: LIVN · Form: 8-K · Filed: Nov 1, 2024 · CIK: 1639691
| Field | Detail |
|---|---|
| Company | Livanova PLC (LIVN) |
| Form Type | 8-K |
| Filed Date | Nov 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, corporate-information
TL;DR
LivaNova PLC filed an 8-K on Nov 1, 2024, covering regulatory disclosures and financial statements.
AI Summary
LivaNova PLC filed an 8-K on November 1, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices in London, United Kingdom, and its fiscal year end of December 31. It also notes previous name changes from Sand Holdco Plc and Sand Holdco Ltd.
Why It Matters
This filing provides essential corporate and financial information for LivaNova PLC, crucial for investors and stakeholders to stay informed about the company's status and reporting requirements.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain any significant new risks or material adverse information.
Key Numbers
- 001-37599 — SEC File Number (Identifies the company's filing with the SEC.)
- 98-1268150 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- LivaNova PLC (company) — Registrant
- November 1, 2024 (date) — Date of Report
- London, United Kingdom (location) — Principal Executive Offices
- Sand Holdco Plc (company) — Former Company Name
- Sand Holdco Ltd (company) — Former Company Name
FAQ
What specific items are covered under the Regulation FD Disclosure?
The provided text does not specify the details of the Regulation FD Disclosure, only that it is an item reported in the 8-K.
What are the primary business activities of LivaNova PLC?
The filing lists LivaNova PLC under Standard Industrial Classification 3845, which is ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS, but does not elaborate on specific business activities.
When did LivaNova PLC change its name from Sand Holdco Plc?
The filing indicates the date of name change from Sand Holdco Plc was April 20, 2015.
What is the fiscal year end for LivaNova PLC?
The fiscal year end for LivaNova PLC is December 31.
What is the physical address of LivaNova PLC's principal executive offices?
The principal executive offices are located at 20 Eastbourne Terrace, London, W2 6LG, United Kingdom.
Filing Stats: 458 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2024-11-01 17:12:22
Filing Documents
- livn-20241101.htm (8-K) — 24KB
- livn-20241101_g1.jpg (GRAPHIC) — 7KB
- 0001639691-24-000139.txt ( ) — 167KB
- livn-20241101.xsd (EX-101.SCH) — 2KB
- livn-20241101_lab.xml (EX-101.LAB) — 22KB
- livn-20241101_pre.xml (EX-101.PRE) — 13KB
- livn-20241101_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On November 1, 2024, the U.S. Centers for Medicare and Medicaid Services (CMS) announced that it is maintaining VNS Therapy for drug-resistant epilepsy (DRE) at the Level 5 Neurostimulator and Related Procedures Ambulatory Payment Classification (APC) under the 2025 Medicare Hospital Outpatient Prospective Payment System. While the Company is disappointed by this decision, it does not believe that this decision will impact the business. LivaNova will continue to pursue reimbursement opportunities for VNS Therapy for DRE.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits. Exhibit Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LivaNova PLC Date: November 1, 2024 By: /s/ Michael Hutchinson Name: Michael Hutchinson Title: SVP, Company Secretary & Chief Legal Officer